×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLSE – pulse biosciences, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLSE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:15 am
plse
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants [Yahoo! Finance]
Low
Report
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants [Yahoo! Finance]
12/19
08:00 am
plse
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
Medium
Report
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
12/17
08:17 am
plse
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery [Yahoo! Finance]
12/17
08:00 am
plse
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
Low
Report
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
12/16
05:59 am
plse
Robert Duggan Spends US$972k On Pulse Biosciences Stock [Yahoo! Finance]
Medium
Report
Robert Duggan Spends US$972k On Pulse Biosciences Stock [Yahoo! Finance]
12/12
11:04 pm
plse
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
12/12
08:17 am
plse
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop [Yahoo! Finance]
Medium
Report
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop [Yahoo! Finance]
11/28
12:02 am
plse
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
05:01 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Dec 11 Filed by: Barrett Burke Thomas
Neutral
Report
Form 4 PULSE BIOSCIENCES, INC. For: Dec 11 Filed by: Barrett Burke Thomas
12/19
06:30 am
plse
Form SCHEDULE 13D/A PULSE BIOSCIENCES, INC. Filed by: DUGGAN ROBERT W
Medium
Report
Form SCHEDULE 13D/A PULSE BIOSCIENCES, INC. Filed by: DUGGAN ROBERT W
12/18
09:37 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Dec 18 Filed by: DUGGAN ROBERT W
Medium
Report
Form 4 PULSE BIOSCIENCES, INC. For: Dec 18 Filed by: DUGGAN ROBERT W
12/17
08:03 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Dec 13 Filed by: DUGGAN ROBERT W
Medium
Report
Form 4 PULSE BIOSCIENCES, INC. For: Dec 13 Filed by: DUGGAN ROBERT W
12/17
06:05 am
plse
Form 4 PULSE BIOSCIENCES, INC. For: Dec 12 Filed by: DUGGAN ROBERT W
Low
Report
Form 4 PULSE BIOSCIENCES, INC. For: Dec 12 Filed by: DUGGAN ROBERT W
12/13
07:31 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Dec 11 Filed by: DUGGAN ROBERT W
Medium
Report
Form 4 PULSE BIOSCIENCES, INC. For: Dec 11 Filed by: DUGGAN ROBERT W
12/6
04:14 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 02
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 02
11/26
12:37 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 26
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 26
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results
33.7%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
TOP News Decliners
2/13
Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology
-29.8%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: